Rachel Margolis-Goodman: Every Contribution Matters. Together, We Research Cures
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared on LinkedIn:
”It is hard to believe after a wonderful week with family and some online shopping, Giving Tuesday is here!
This past year, I decided to completely change my career and entered the fundraising world, and I am so grateful I did.
So on this giving Tuesday, perhaps you could consider giving back to the Versiti Blood Research Institute or Versiti on King!
Both the VBRI and Versiti on King is transforming blood health together!
From breakthrough research in our labs to trusted partnerships in our communities, Versiti is driving change at every level.
At Versiti Blood Research Institute, scientists are researching cures every day with the hope to eradicate blood disease.
At the VBRI we are driving breakthroughs in blood health, from stem cell biology to immunology.
This cutting edge research saves lives and will help shape the future of medicine.
Through Versiti on King (VOK), we’re connecting neighbors to resources, hosting blood typing events, community education events, and partnering with communities to improve health equity.
Through our programs this year, 170 people discovered they carry Ro-positive blood, the safest type for patients with sickle cell disease.
If you are unable to donate financially, please consider scheduling a blood donation today to help save up to 3 lives!
Every contribution matters. Together, we research cures.
Make your Giving Tuesday gift:
Stay updated on the emerging with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines